School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Jeffrey Boatright PhD

  • Department of Ophthalmology
    Professor
  • (404) 778-4113
  • jeffboatright@emory.edu
Head shot of Jeffrey Boatright

Overview

Dr. Boatright is a Professor in the Department of Ophthalmology and a Research Biologist and Core Director at the Atlanta Veterans Administration Medical Center. He is a graduate of Brown University (ScB in Neural Sciences and Experimental Psychology) and Emory University (PhD in Pharmacology and the Neurosciences Training Program).

He joined the faculty of the Department of Ophthalmology in 1999, conducting research on the regulation of retinal gene expression, a study funded by an R01 grant from the National Institutes of Health National Eye Institute (NIH NEI). This research expanded into using endogenous DNA repair mechanisms to treat genetic mutations that lead to blindness.

Currently Dr. Boatright is exploring whether physiological preconditioning stressors such as bright light, whole-body exercise, and mild hypoxia/ischemia elevate DNA repair rates, also funded by an NEI R01. This has led to separate projects testing the effects of exercise in rodent models of retinal degeneration, diabetic retinopathy, and glaucoma. Some of this work has extended to testing effects of exercise on visual functions in humans, a project supported by individual and program grants from the Veterans Administration.

In a separate project, Dr. Boatright uses in vivo pharmacological approaches to explore the effects of atypical, endogenous compounds on animal models of retinal degeneration and glaucoma. This work has been funded by the Katz Foundation, Foundation Fighting Blindness, NIH National Center for Complementary and Alternative Medicine (NIH NCCAM), and a Center Award from the Veterans Administration.

Currently Dr. Boatright is principal investigator or co-investigator in four NEI grants, three VA grants, and two private foundation grants.

Dr. Boatright is founding and current editor-in-chief of Molecular Vision, a peer-reviewed online journal dedicated to the dissemination of research results in molecular biology, cell biology and the genetics of the visual system. The journal is ranked second in a field of 14 competing journals and is routinely used as an open access exemplar by the National Library of Medicine and The National Institutes of Health Library. The journal is supported by international and local academic partnerships and through initiatives generated in the Department of Ophthalmology. Dr. Boatright also serves on the editorial boards of two other journals.

Dr. Boatright is on the Board of Governors of the Association for Research in Vision and Ophthalmology (ARVO), the preeminent professional society for vision research nationally and internationally. Prior to this, he served for seven years on the Board of Trustees and was President in 2011-2012. He was designated a Silver and then a Gold Fellow in 2010 and 2012, respectively, in recognition of his individual accomplishments, leadership, and contributions to the Association. In 2016-17, he successfully led the effort to create and publish an online education course that bridges all aspects of basic, translational, and clinical vision research.

Dr. Boatright directs IBS548, the graduate portion of the course BIOL475 Biology of the Eye. He routinely lectures in courses offered by EUSOMs Office of Faculty Affairs and Professional Development and the Office of Postdoctoral Education.

Academic Appointment

  • Professor, Department of Ophthalmology, Emory University School of Medicine

Education

Degrees

  • PhD from Emory University School of Medicine,
  • Sc.B. from Brown University

Research

Focus

  • Retina-specific gene regulation. Oligonucleotide-directed DNA repair gene therapy. Transcleral ionotophoretic delivery of pharmaceuticals and DNA constructs. Neuroprotectants in treatment of retinal degenerations and glaucoma. Development of new animal models of retinal degeneration. Exercise preconditioning as retinal protectant therapy. Role of metabolic regulation in retinal health, damage, and disease.

Publications

  • Tauroursodeoxycholic Acid Protects Retinal Ganglion Cells and Reduces Inflammation in Mice Following Optic Nerve Crush.
    Pharmaceuticals (Basel) Volume: 18
    04/14/2025 Authors: Zhang N; Li Y; Zhang X; Chrenek MA; Wang J; Girardot PE; Sellers JT; Geisert EE; Nickerson JM; Boatright JH
  • Accessible LED Lightbox for Light-induced Retinal Damage in Pigmented Mice.
    Invest Ophthalmol Vis Sci Volume: 66 Page(s): 49
    02/03/2025 Authors: Aliff HL; Crockett AB; Chrenek MA; Nickerson JM; Boatright JH; Tseytlin O; Johnson M; Bockius HG; Kuzak SG; Ramamurthy V
  • Temporal Regulation of Myopia and Inflammation-Associated Pathways in the Interphotoreceptor Retinoid-Binding Protein Knockout Mouse Model.
    Curr Eye Res Volume: 50 Page(s): 221 - 230
    02/01/2025 Authors: Markand S; Kim S; Chrenek MA; Ferdous S; Priyadarshani P; Boatright JH; Nickerson JM
  • High resolution imaging and interpretation of three-dimensional RPE sheet structure.

    01/28/2025 Authors: Donaldson KJ; Chrenek MA; Boatright JH; Nickerson JM
  • An improved method of transducing retinal ganglion cells using AAV via transpupillary injection in adult mouse eyes.
    Mol Vis Volume: 31 Page(s): 1 - 9
    01/01/2025 Authors: Lin F; Lin S-T; Wang J; Sellers JT; Chrenek MA; Nickerson JM; Boatright JH; Geisert EE
  • Loss of Pigment Epithelium Derived Factor Sensitizes C57BL/6J Mice to Light-Induced Retinal Damage.

    12/04/2024 Authors: Shelton DA; Papania JT; Getz TE; Sellers JT; Giradot PE; Chrenek MA; Grossniklaus HE; Boatright JH; Nickerson JM
  • Conditional Knockouts of Interphotoreceptor Retinoid Binding Protein Suggest Two Independent Mechanisms for Retinal Degeneration and Myopia.
    Invest Ophthalmol Vis Sci Volume: 65 Page(s): 32
    06/03/2024 Authors: Getz TE; Chrenek MA; Papania JT; Shelton DA; Markand S; Iuvone PM; Kozmik Z; Boatright JH; Nickerson JM
  • POU6F2, a risk factor for glaucoma, myopia and dyslexia, labels specific populations of retinal ganglion cells.
    Sci Rep Volume: 14 Page(s): 10096
    05/02/2024 Authors: Lin F; Li Y; Wang J; Jardines S; King R; Chrenek MA; Wiggs JL; Boatright JH; Geisert EE
  • Voluntary exercise preserves visual function and reduces inflammatory response in an adult mouse model of autosomal dominant retinitis pigmentosa.
    Sci Rep Volume: 14 Page(s): 6940
    03/23/2024 Authors: Bales KL; Karesh AM; Hogan K; Chacko AS; Douglas GL; Feola AJ; Nickerson JM; Pybus A; Wood L; Boatright JH
  • Age-Related RPE changes in Wildtype C57BL/6J Mice between 2 and 32 Months.
    bioRxiv
    02/01/2024 Authors: Shelton DA; Gefke I; Summers V; Kim Y-K; Yu H; Getz Y; Ferdous S; Donaldson K; Liao K; Papania JT
  • Pentosan Polysulfate Sodium Causes Diminished Function and Subtle Morphological Changes in Retina and RPE of Mice.
    Invest Ophthalmol Vis Sci Volume: 65 Page(s): 28
    02/01/2024 Authors: Girardot PE; Zhang X; Zhang N; Donaldson KJ; Chrenek MA; Sellers JT; Feola AJ; Papania J; Nickerson JM; Jain N
  • Retinal and metabolic changes in a high-fat diet (HFD)+STZ model of Type II diabetes.
    Mol Vis Volume: 30 Page(s): 239 - 259
    01/01/2024 Authors: Phillips S; Feola A; Solomon J; Cardelle L; Douglass A; Bales KL; Coulter M; Hutson L; Khayat CT; Grubman A
  • Systemic treatment with nicotinamide riboside is protective in two mouse models of retinal ganglion cell damage
    Volume: 39 Page(s): A24 - A25
    10/01/2023 Authors: Zhang X; Zhang N; Li Y; Wang J; Micah CA; Preston J; Nickerson J; Boatright JH
  • Oral supplementary nicotinamide riboside protects function in a model of inherited mouse glaucoma
    Volume: 39 Page(s): A20 - A20
    10/01/2023 Authors: Li Y; Zhang N; Zhang X; Chrenek MA; Wang J; Sellers JT; Charles B; Geisert E; Boatright JH
  • Systemic Treatment with Tauroursodeoxycholic Acid (TUDCA) enhances retinal ganglion cell survival following optic nerve crush
    Volume: 39 Page(s): A35 - A36
    10/01/2023 Authors: Zhang N; Li Y; Zhang X; Chrenek MA; Wang J; Girardot PE; Sellers JT; Geisert EE; Nickerson JM; Boatright JH
  • Knocking out Stat3 in rod photoreceptor cells unexpectedly protects against light-induced retinal degeneration
    Volume: 64
    06/01/2023 Authors: Sellers J; Chrenek M; Garcia M; Still A; Iuvone P; Nickerson J; Boatright J
  • Voluntary exercise modulates pathways associated with amelioration of retinal degenerative diseases.
    Front Physiol Volume: 14 Page(s): 1116898
    01/01/2023 Authors: Chu-Tan JA; Cioanca AV; Wooff Y; Kirkby M; Ellis M; Gulati P; Karl T; Boatright JH; Bales K; Nickerson J
  • Deletion of histone demethylase Lsd1 (Kdm1a) during retinal development leads to defects in retinal function and structure.
    Front Cell Neurosci Volume: 17 Page(s): 1104592
    01/01/2023 Authors: Ferdous S; Shelton DA; Getz TE; Chrenek MA; L'Hernault N; Sellers JT; Summers VR; Iuvone PM; Boss JM; Boatright JH
  • Treadmill exercise promotes retinal astrocyte plasticity and protects against retinal degeneration in a mouse model of light-induced retinal degeneration.
    J Neurosci Res Volume: 100 Page(s): 1695 - 1706
    09/01/2022 Authors: Bales KL; Chacko AS; Nickerson JM; Boatright JH; Pardue MT
  • Subretinal expression of Galectin-3 after light-induced retinal damage
    Volume: 63
    06/01/2022 Authors: Shelton D; Sellers JT; Chrenek M; Getz T; Summers V; Girardot PE; Modgil S; Boatright JH; Nickerson JM
  • Systemic treatment with Cucurbitacin I protects in light-induced retinal degeneration (LIRD) mice
    Volume: 63
    06/01/2022 Authors: Douglas GL; Chrenek M; Sellers JT; Reid C; Nickerson JM; Bales K; Boatright JH
  • Conditional late deletion of IRBP causes loss of retinal function and a slow retinal degeneration without myopic eye elongation
    Volume: 63
    06/01/2022 Authors: Getz T; Chrenek M; Reid C; Shelton D; Summers V; Boatright JH; Nickerson JM
  • Systemic treatment with methylsulfonylmethane protects against light-induced retinal degeneration
    Volume: 63
    06/01/2022 Authors: Still AB; Sellers JT; Chrenek M; Nickerson JM; Boatright JH
  • Inexpensive LED light box for modeling light-induced retinal degeneration in pigmented C57Black mice
    Volume: 63
    06/01/2022 Authors: Aliff H; Nickerson JM; Boatright J; Chrenek M; Tseytlin O; Ramamurthy V
  • Pentosan Polysulfate Retinopathy in Mice Involves Subtle Changes in Outer Segment Length and RPE Cell Size
    Volume: 63
    06/01/2022 Authors: Girardot PE; Zhang X; Zhang N; Donaldson KJ; Chrenek M; Sellers JT; Jain N; Nickerson JM; Boatright JH
  • Exercise promotes BDNF and specific TrkB isoform expression in retinal astrocytes and protects against retinal degeneration
    Volume: 63
    06/01/2022 Authors: Bales K; Chacko A; Nickerson JM; Pardue MT; Boatright JH
  • Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models.
    Pharmaceuticals (Basel) Volume: 15
    03/09/2022 Authors: Daruich A; Picard E; Gugan J; Jaworski T; Parenti L; Delaunay K; Naud M-C; Berdugo M; Boatright JH; Behar-Cohen F
  • A Tropomycin-Related Kinase B Receptor Activator for the Management of Ocular Blast-Induced Vision Loss.
    J Neurotrauma Volume: 38 Page(s): 2896 - 2906
    10/15/2021 Authors: Dhakal S; He L; Lyuboslavsky P; Sidhu C; Chrenek MA; Sellers JT; Boatright JH; Geisert EE; Setterholm NA; McDonald FE
  • Tauroursodeoxycholic Acid Protects Retinal and Visual Function in a Mouse Model of Type 1 Diabetes.
    Pharmaceutics Volume: 13
    07/27/2021 Authors: Fu J; Aung MH; Prunty MC; Hanif AM; Hutson LM; Boatright JH; Pardue MT
  • Electrophysiologic and Morphologic Strain Differences in a Low-Dose NaIO3-Induced Retinal Pigment Epithelium Damage Model.
    Transl Vis Sci Technol Volume: 10 Page(s): 10
    07/01/2021 Authors: Zhang N; Zhang X; Girardot PE; Chrenek MA; Sellers JT; Li Y; Kim Y-K; Summers VR; Ferdous S; Shelton DA
  • Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage.
    Pharmaceutics Volume: 13
    06/16/2021 Authors: Zhang X; Zhang N; Chrenek MA; Girardot PE; Wang J; Sellers JT; Geisert EE; Brenner C; Nickerson JM; Boatright JH
  • Age-Related Retinal Changes in Wild-Type C57BL/6J Mice Between 2 and 32 Months.
    Invest Ophthalmol Vis Sci Volume: 62 Page(s): 9
    06/01/2021 Authors: Ferdous S; Liao KL; Gefke ID; Summers VR; Wu W; Donaldson KJ; Kim Y-K; Sellers JT; Dixon JA; Shelton DA
  • Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model.
    Neurotherapeutics Volume: 18 Page(s): 1325 - 1338
    04/01/2021 Authors: Daruich A; Jaworski T; Henry H; Zola M; Youale J; Parenti L; Naud M-C; Delaunay K; Bertrand M; Berdugo M
  • Morphometric Analysis of Retinal Pigment Epithelial Cells From C57BL/6J Mice During Aging.
    Invest Ophthalmol Vis Sci Volume: 62 Page(s): 32
    02/01/2021 Authors: Kim Y-K; Yu H; Summers VR; Donaldson KJ; Ferdous S; Shelton D; Zhang N; Chrenek MA; Jiang Y; Grossniklaus HE
  • The Effect of Aerobic Exercise on Physical and Cognitive Outcomes in a Small Cohort of Outpatients with Schizophrenia.
    Brain Plast Volume: 5 Page(s): 161 - 174
    10/01/2020 Authors: Massa N; Alrohaibani A; Mammino K; Bello M; Taylor N; Cuthbert B; Fargotstein M; Coulter MM; Boatright JH; Nocera J
  • Systemic Treatment With Nicotinamide Riboside Is Protective in a Mouse Model of Light-Induced Retinal Degeneration.
    Invest Ophthalmol Vis Sci Volume: 61 Page(s): 47
    08/03/2020 Authors: Zhang X; Henneman NF; Girardot PE; Sellers JT; Chrenek MA; Li Y; Wang J; Brenner C; Nickerson JM; Boatright JH
  • Age-related Ocular Changes in C57BL/6J mice from P30-P930
    Volume: 61
    06/01/2020 Authors: Persons V; Ferdous S; Liao KL; Wu W; Donaldson KJ; Gefke I; Kim Y-K; Shelton D; Sellers JT; Markand S
  • Exercise promotes astrocyte plasticity and protects against retinal degeneration
    Volume: 61
    06/01/2020 Authors: Bales KL; Chacko A; Pardue M; Boatright JH
  • Systemic Treatment with Nicotinamide Riboside is Protective in Four Mouse Models of Retinal Degeneration
    Volume: 61
    06/01/2020 Authors: Zhang X; Henneman N; Girardot PE; Li Y; Zhang N; Sellers JT; Chrenek MA; Wang J; Geisert EE; Brenner C
  • Optimization of a Retinal Pigment Epithelium Damage Model
    Volume: 61
    06/01/2020 Authors: Zhang N; Zhang X; Girardot P; Summers V; Sellers JT; Li Y; Chrenek MA; Nickerson JM; Boatright JH
  • Drug Tissue Distribution of TUDCA From a Biodegradable Suprachoroidal Implant versus Intravitreal or Systemic Delivery in the Pig Model.
    Transl Vis Sci Technol Volume: 9 Page(s): 11
    05/01/2020 Authors: Olsen TW; Dyer RB; Mano F; Boatright JH; Chrenek MA; Paley D; Wabner K; Schmit J; Chae JB; Sellers JT
  • Characterization of LSD1 Expression Within the Murine Eye.
    Invest Ophthalmol Vis Sci Volume: 60 Page(s): 4619 - 4631
    11/01/2019 Authors: Ferdous S; Grossniklaus HE; Boatright JH; Nickerson JM
  • Exercise protects against retinal degeneration and retinal pigment epithelium (RPE) stress in the RHOtvrm4/+ mouse model of retinitis pigmentosa
    Volume: 60
    07/01/2019 Authors: Zhang X; Girardot P; Sellers JT; Wu W; Skelton H; Nickerson JM; Pardue MT; Boatright JH
  • Novel in and ex vivo methods to reveal abnormal RPE morphology and microglial cell migration following light-induced retinal damage
    Volume: 60
    07/01/2019 Authors: Wu W; Donaldson KJ; Liao KL; Gefke I; Boatright JH; Grossniklaus HE; Nickerson JM
  • Characterization and functional analysis of Lsd1 within the murine eye
    Volume: 60
    07/01/2019 Authors: Ferdous S; Gefke I; Boatright JH; Grossniklaus HE; Nickerson JM
  • Treatment of retinoblastoma cells with TCP induces dose-dependent cell death
    Volume: 60
    07/01/2019 Authors: Rha J; Ferdous S; Chrenek MA; Griffin M; Boatright JH; Grossniklaus HE; Nickerson JM
  • Adjuvant ursodeoxycholic acid for retinal detachment : a potential neuroprotective therapy
    Volume: 60
    07/01/2019 Authors: Daruich A; Picard E; Zola M; Henry H; Boatright JH; Behar-Cohen FF
  • The effects of old age on RD and myopia in IRBP KO mice
    Volume: 60
    07/01/2019 Authors: Liao KL; Markand S; Ferdous S; Donaldson KJ; Boatright JH; Nickerson JM
  • Rpe65 L450 allele increases sensitivity to light damage in C57BL/6J mice
    Volume: 60
    07/01/2019 Authors: Chrenek MA; Sellers JT; Liao KL; Still B; Nickerson JM; Boatright JH
  • Interphotoreceptor Retinoid-Binding Protein (IRBP) prevents myopia, independent of mouse genetic backgrounds
    Volume: 60
    07/01/2019 Authors: Markand S; Kim S; Chrenek MA; Boatright JH; Nickerson JM
  • Retina transcriptome underlie the neuroprotective actions of transferrin
    Volume: 60
    07/01/2019 Authors: Emilie P; Daruich A; Lerouzic Q; Naud M-C; Jonet L; Kowalczuk L; Pournaras J-A; Boatright JH; Thomas A; Turck N
  • Low-Intensity Exercise in Mice Is Sufficient to Protect Retinal Function During Light-Induced Retinal Degeneration.
    Invest Ophthalmol Vis Sci Volume: 60 Page(s): 1328 - 1335
    04/01/2019 Authors: Mees LM; Coulter MM; Chrenek MA; Motz CT; Landis EG; Boatright JH; Pardue MT
  • Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease.
    Mol Vis Volume: 25 Page(s): 610 - 624
    01/01/2019 Authors: Daruich A; Picard E; Boatright JH; Behar-Cohen F
  • Initial Assessment of Lactate as Mediator of Exercise-Induced Retinal Protection.
    Adv Exp Med Biol Volume: 1185 Page(s): 451 - 455
    01/01/2019 Authors: Sellers JT; Chrenek MA; Girardot PE; Nickerson JM; Pardue MT; Boatright JH
  • Analysis of Damage and Wound Healing in theRetinal Pigmented Epithelium.
    Adv Exp Med Biol Volume: 1185 Page(s): 425 - 430
    01/01/2019 Authors: Donaldson KJ; Wu WF; Skelton H; Markand S; Ferdous S; Sellers J; Chrenek MA; Gefke I; Kim SM; Rha J
  • Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.
    Mol Vis Volume: 25 Page(s): 462 - 476
    01/01/2019 Authors: Zhang X; Girardot PE; Sellers JT; Li Y; Wang J; Chrenek MA; Wu W; Skelton H; Nickerson JM; Pardue MT
  • Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection.
    Sci Adv Volume: 5 Page(s): eaau9940
    01/01/2019 Authors: Daruich A; Le Rouzic Q; Jonet L; Naud M-C; Kowalczuk L; Pournaras J-A; Boatright JH; Thomas A; Turck N; Moulin A
  • Characterization of magnetofection transfection reagent, a novel transfection method for gene therapy in a mouse model
    Volume: 59
    07/01/2018 Authors: Priyadarshani P; Ferdous S; Markand S; Donaldson KJ; Boatright JH; Nickerson JM
  • RHO-tvrm4 mice lacking STAT2 are resistant to light induced retinal degeneration
    Volume: 59
    07/01/2018 Authors: Chrenek MA; Sellers JT; Girardot P; Nickerson JM; Nava P; Boatright JH
  • Interaction between underlying pathways in IRBP induced myopia.
    Volume: 59
    07/01/2018 Authors: Markand S; Wong P; Boatright JH; Nickerson JM
  • TrkB signalling pathway mediates the protective effects of exercise in the diabetic rat retina.
    Eur J Neurosci Volume: 47 Page(s): 1254 - 1265
    05/01/2018 Authors: Allen RS; Hanif AM; Gogniat MA; Prall BC; Haider R; Aung MH; Prunty MC; Mees LM; Coulter MM; Motz CT
  • Set screw homogenization of murine ocular tissue, including the whole eye.
    Mol Vis Volume: 24 Page(s): 690 - 699
    01/01/2018 Authors: Gooding SW; Chrenek MA; Ferdous S; Nickerson JM; Boatright JH
  • Differential Exon Expression in a Large Family of Retinal Genes Is Regulated by a Single Trans Locus.
    Adv Exp Med Biol Volume: 1074 Page(s): 413 - 420
    01/01/2018 Authors: Wang J; Struebing FL; Ferdous S; Donaldson K; Boatright JH; Geisert EE; Nickerson JM
  • Daily visual stimulation in the critical period enhances multiple aspects of vision through BDNF-mediated pathways in the mouse retina.
    PLoS One Volume: 13 Page(s): e0192435
    01/01/2018 Authors: Mui AM; Yang V; Aung MH; Fu J; Adekunle AN; Prall BC; Sidhu CS; Park HN; Boatright JH; Iuvone PM
  • Xanthohumol Protects Morphology and Function in a Mouse Model of Retinal Degeneration.
    Invest Ophthalmol Vis Sci Volume: 59 Page(s): 45 - 53
    01/01/2018 Authors: Henneman NF; Foster SL; Chrenek MA; Sellers JT; Wright CB; Schmidt RH; Nickerson JM; Boatright JH
  • Aerobic Exercise as an Adjuvant to Aphasia Therapy: Theory, Preliminary Findings, and Future Directions.
    Clin Ther Volume: 40 Page(s): 35 - 48.e6
    01/01/2018 Authors: Harnish SM; Rodriguez AD; Blackett DS; Gregory C; Seeds L; Boatright JH; Crosson B
  • Comparison of complement pathway activation and synapse loss in young and aged mice undergoing light induced retinal degeneration
    Volume: 58
    06/01/2017 Authors: Gooding SW; Chrenek MA; Sellers JT; Boatright JH
  • Modeling Pharmacological Treatment of Retinitis Pigmentosa with Heterozygous Tvrm4 Rhodopsin Mutant Mice
    Volume: 58
    06/01/2017 Authors: Schmidt RH; Girardot PE; Sellers JT; Chrenek MA; Boatright JH
  • Comparison of the RHO-tvrm4 and light damage models of retinal degeneration
    Volume: 58
    06/01/2017 Authors: Chrenek MA; Gooding SW; Sellers JT; Schmidt RH; Henneman NF; Girardot PE; Boatright JH
  • Retinal Degeneration is Time- and Intensity-Dependent in Heterozygous Carriers of the Tvrm4 Rhodopsin Mutation
    Volume: 58
    06/01/2017 Authors: Girardot PE; Schmidt RH; Sellers JT; Boatright JH
  • Systemic treatment with xanthohumol protects against light-induced retinal degeneration and maintains retinal redox potential
    Volume: 58
    06/01/2017 Authors: Henneman NF; Foster S; Girardot PE; Boatright JH
  • TUDCA and DMSO additively protect against light-induced retinal degeneration
    Volume: 58
    06/01/2017 Authors: Sellers JT; Chrenek MA; Henneman NF; Boatright JH
  • Assessment of efficacy of Magnetofection transfection system in delivering genes to RPE cells, a novel transfection method for gene therapy in mouse model
    Volume: 58
    06/01/2017 Authors: Priyadarshani P; Markand S; Sellers JT; Boatright JH; Nickerson JM
  • Upregulation of myopia-related genes in the Interphotoreceptor retinoid-binding protein (IRBP) knockout (KO) mouse model
    Volume: 58
    06/01/2017 Authors: Markand S; Chrenek MA; Priyadarshani P; Boatright JH; Nickerson JM
  • Low-to-moderate intensity forced exercise protects retinal function from light-induced retinal degeneration
    Volume: 58
    06/01/2017 Authors: Mees L; Coulter M; Chrenek MA; Motz CT; Landis E; Boatright JH; Pardue MT
  • Intravitreal injection vs. topical eye drop application of nanoparticles using a mouse model
    Volume: 57
    09/01/2016 Authors: Wetzstein S; Sellers JT; Donaldson K; Unger G; Markand S; Priyadarshani P; Boatright JH; Nickerson JM
  • Retinal defects in mice after lvermectin treatment
    Volume: 57
    09/01/2016 Authors: Chrenek MA; Sellers JT; Masters B; Struebing FL; King R; Cunha PP; Taylor D; Boatright JH; Nickerson JM; Iuvone PM
  • Embryonic chick retinal cell cultures: a model for Light-Induced Retinal Degeneration (LIRD)
    Volume: 57
    09/01/2016 Authors: Schmidt RH; Henneman NF; Girardot PE; Gooding SW; Cunha PP; Boatright JH
  • Protection from blast-induced vision loss by the N-acetylserotonin derivative HIOC through a BDNF/TrkB receptor mechanism
    Volume: 57
    09/01/2016 Authors: Luvone PM; Lyuboslaysky P; Sidhu C; He L; Boatright JH; Geisert EE
  • Pupillary responses in the C57BL/6J and congenic IRBP knockout mouse
    Volume: 57
    09/01/2016 Authors: Donaldson KJ; Markand S; Sellers JT; Chrenek MA; Pardue MT; Luvone PM; Boatright JH; Nickerson JM
  • Ocular parameters changes in the IRBP knockout mouse eye
    Volume: 57
    09/01/2016 Authors: Markand S; Wetzstein SA; Williams N; Chakraborty R; Priyadarshani P; Donaldson K; Boatright JH; Pardue MT; Nickerson JM
  • Tauroursodeoxycholic Acid Protects Visual Function in a Mouse Model of Type 1 Diabetes
    Volume: 57
    09/01/2016 Authors: Fu J; Aung M; Prunty M; Hanif A; Boatright JH; Pardue MT
  • Alternative splicing in the retina in a large family of genes is regulated by a single trans locus
    Volume: 57
    09/01/2016 Authors: Nickerson JM; Struebing FL; Markand S; Donaldson K; Ferdous S; Boatright JH; Geisert EE
  • Clustered Regularly Interspaced Short Palindromic Repeats: Challenges in Treating Retinal Disease.
    Asia Pac J Ophthalmol (Phila) Volume: 5 Page(s): 304 - 308
    01/01/2016 Authors: Chrenek MA; Nickerson JM; Boatright JH
  • Analysis of RPE morphometry in human eyes.
    Mol Vis Volume: 22 Page(s): 898 - 916
    01/01/2016 Authors: Bhatia SK; Rashid A; Chrenek MA; Zhang Q; Bruce BB; Klein M; Boatright JH; Jiang Y; Grossniklaus HE; Nickerson JM
  • IRBP deficiency permits precocious ocular development and myopia.
    Mol Vis Volume: 22 Page(s): 1291 - 1308
    01/01/2016 Authors: Markand S; Baskin NL; Chakraborty R; Landis E; Wetzstein SA; Donaldson KJ; Priyadarshani P; Alderson SE; Sidhu CS; Boatright JH
  • Exercise as Gene Therapy: BDNF and DNA Damage Repair.
    Asia Pac J Ophthalmol (Phila) Volume: 5 Page(s): 309 - 311
    01/01/2016 Authors: Schmidt RH; Nickerson JM; Boatright JH
  • Tauroursodeoxycholic Acid Protects Retinal Function and Structure in rd1 Mice.
    Adv Exp Med Biol Volume: 854 Page(s): 431 - 436
    01/01/2016 Authors: Lawson EC; Bhatia SK; Han MK; Aung MH; Ciavatta V; Boatright JH; Pardue MT
  • Exercise and Cyclic Light Preconditioning Protect Against Light-Induced Retinal Degeneration and Evoke Similar Gene Expression Patterns.
    Adv Exp Med Biol Volume: 854 Page(s): 443 - 448
    01/01/2016 Authors: Chrenek MA; Sellers JT; Lawson EC; Cunha PP; Johnson JL; Girardot PE; Kendall C; Han MK; Hanif A; Ciavatta VT
  • RPE Cell and Sheet Properties in Normal and Diseased Eyes.
    Adv Exp Med Biol Volume: 854 Page(s): 757 - 763
    01/01/2016 Authors: Rashid A; Bhatia SK; Mazzitello KI; Chrenek MA; Zhang Q; Boatright JH; Grossniklaus HE; Jiang Y; Nickerson JM
  • Neuroprotective Effects of Voluntary Exercise in an Inherited Retinal Degeneration Mouse Model.
    Invest Ophthalmol Vis Sci Volume: 56 Page(s): 6839 - 6846
    10/01/2015 Authors: Hanif AM; Lawson EC; Prunty M; Gogniat M; Aung MH; Chakraborty R; Boatright JH; Pardue MT
  • In Vivo Imaging of Retinal Oxidative Stress Using a Reactive Oxygen Species-Activated Fluorescent Probe.
    Invest Ophthalmol Vis Sci Volume: 56 Page(s): 5862 - 5870
    09/01/2015 Authors: Prunty MC; Aung MH; Hanif AM; Allen RS; Chrenek MA; Boatright JH; Thule PM; Kundu K; Murthy N; Pardue MT
  • Gram-scale, chemoselective synthesis of N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-2-oxopiperidine-3-carboxamide (HIOC).
    Tetrahedron Lett Volume: 56 Page(s): 3413 - 3415
    06/03/2015 Authors: Setterholm NA; McDonald FE; Boatright JH; Iuvone PM
  • Traumatic Blast-Induced Closed Globe Injury Reduces Visual Function and Retinal Ganglion Cells of Thy1-CFP mice: Mitigation by a Small Molecule TrkB Activator
    Volume: 56
    06/01/2015 Authors: Sidhu C; Lyuboslavsky P; Chrenek MA; Struebing FL; Sellers JT; Setterholm NA; McDonald FE; Boatright JH; Geisert EE; Iuvone PM
  • Voluntary Exercise is Neuroprotective in an Inherited Retinal Degeneration Mouse Model
    Volume: 56
    06/01/2015 Authors: Hanif A; Lawson E; Prunty M; Gogniat M; Aung MH; Chakraborty R; Chrenek MA; Boatright JH; Pardue MT
  • Eye Elongation and Retinal Degeneration in the IRBP Knockout Mouse
    Volume: 56
    06/01/2015 Authors: Williams N; Getz S; Sidhu C; Boatright JH; Pardue MT; Iuvone PM; Nickerson JM
  • Three-dimensional properties of diseased and normal RPE cell sheets
    Volume: 56
    06/01/2015 Authors: Ziesel AC; Rashid A; Bhatia S; Mazzitello K; Chrenek MA; Zhang Q; Boatright JH; Grossniklaus HE; Jiang Y; Nickerson JM
  • Examination of the mechanism of retinal protection by DMSO in murine light damage
    Volume: 56
    06/01/2015 Authors: Chrenek MA; Sellers JT; Foster SL; Iuvone PM; Boatright JH
  • Progesterone treatment in two rat models of ocular ischemia.
    Invest Ophthalmol Vis Sci Volume: 56 Page(s): 2880 - 2891
    05/01/2015 Authors: Allen RS; Olsen TW; Sayeed I; Cale HA; Morrison KC; Oumarbaeva Y; Lucaciu I; Boatright JH; Pardue MT; Stein DG
  • Potential Role of Exercise in Retinal Health.
    Prog Mol Biol Transl Sci Volume: 134 Page(s): 491 - 502
    01/01/2015 Authors: Pardue MT; Chrenek MA; Schmidt RH; Nickerson JM; Boatright JH
  • Methodologies for analysis of patterning in the mouse RPE sheet.
    Mol Vis Volume: 21 Page(s): 40 - 60
    01/01/2015 Authors: Boatright JH; Dalal N; Chrenek MA; Gardner C; Ziesel A; Jiang Y; Grossniklaus HE; Nickerson JM
  • The Rpe65 rd12 allele exerts a semidominant negative effect on vision in mice.
    Invest Ophthalmol Vis Sci Volume: 55 Page(s): 2500 - 2515
    04/17/2014 Authors: Wright CB; Chrenek MA; Feng W; Getz SE; Duncan T; Pardue MT; Feng Y; Redmond TM; Boatright JH; Nickerson JM
  • Early Morphological Changes in IRBP Knockout Mice
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 55
    04/01/2014 Authors: Getz S; Chrenek MA; Williams N; Boatright JH; Nickerson JM
  • Brief-Period Light Preconditioning: Effects of Intensity
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 55
    04/01/2014 Authors: Girardot P; Chrenek MA; Cunha P; Sellers J; Nickerson JM; Boatright JH
  • Severity of middle cerebral artery occlusion determines retinal deficits in rats.
    Exp Neurol Volume: 254 Page(s): 206 - 215
    04/01/2014 Authors: Allen RS; Sayeed I; Cale HA; Morrison KC; Boatright JH; Pardue MT; Stein DG
  • Coincident birth of the IRBP gene and the vertebrate eye
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 55
    04/01/2014 Authors: Nickerson JM; Williams N; Getz S; Chrenek MA; Boatright JH
  • IRBP, Dopamine, and the Development of Early Myopia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 55
    04/01/2014 Authors: Williams N; Getz S; Aseem F; Sidhu CS; Boatright JH; Iuvone PM; Nickerson JM
  • Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion
    Volume: 55
    04/01/2014 Authors: Allen RS; Sayeed I; Oumarbaeva Y; Morrison K; Lucaciu I; Cale H; Choi PH; Boatright JH; Pardue MT; Stein DG
  • Fluorescent probes for in vivo detection of oxidative stress within the eye
    Volume: 55
    04/01/2014 Authors: Prunty M; Aung MH; Boatright JH; Murthy N; Thule P; Pardue MT
  • Daily optokinetic testing improves contrast sensitivity through BDNF-mediated pathways
    Volume: 55
    04/01/2014 Authors: Mui A; Prall BC; Aung MH; Obertone T; Park H; Boatright JH; Pardue MT
  • Aerobic Exercise Sustains Retinal Function and Retinal Dopamine Metabolism in Diabetic Rats
    Volume: 55
    04/01/2014 Authors: Prall BC; Aung MH; Gogniat M; Allen RS; Sidhu CS; Boatright JH; Iuvone PM; Pardue MT
  • Tauroursodeoxycholic acid (TUDCA) protects against human sub-retinal fluid toxicity in photoreceptor-enriched chick cell cultures
    Volume: 55
    04/01/2014 Authors: Cunha P; Aseem F; Daruich A; Johnson W; Girardot P; Chrenek MA; Iuvone PM; Behar-Cohen FF; Boatright JH
  • Novel method for quantifying loss of retinal ganglion cells in mice
    Volume: 55
    04/01/2014 Authors: Chrenek MA; Sellers J; Foster SL; Iuvone PM; Boatright JH
  • Aerobic exercise protects retinal function and structure from light-induced retinal degeneration.
    J Neurosci Volume: 34 Page(s): 2406 - 2412
    02/12/2014 Authors: Lawson EC; Han MK; Sellers JT; Chrenek MA; Hanif A; Gogniat MA; Boatright JH; Pardue MT
  • DNA delivery in adult mouse eyes: an update with corneal outcomes.
    Methods Mol Biol Volume: 1121 Page(s): 165 - 177
    01/01/2014 Authors: Nickerson JM; Getz SE; Sellers JT; Chrenek MA; Goodman P; Bernal CJ; Boatright JH
  • Analysis of mouse RPE sheet morphology gives discriminatory categories.
    Adv Exp Med Biol Volume: 801 Page(s): 601 - 607
    01/01/2014 Authors: Jiang Y; Qi X; Chrenek MA; Gardner C; Dalal N; Boatright JH; Grossniklaus HE; Nickerson JM
  • N-acetylserotonin: circadian activation of the BDNF receptor and neuroprotection in the retina and brain.
    Adv Exp Med Biol Volume: 801 Page(s): 765 - 771
    01/01/2014 Authors: Iuvone PM; Boatright JH; Tosini G; Ye K
  • Functional principal component analysis reveals discriminating categories of retinal pigment epithelial morphology in mice.
    Invest Ophthalmol Vis Sci Volume: 54 Page(s): 7274 - 7283
    11/05/2013 Authors: Jiang Y; Qi X; Chrenek MA; Gardner C; Boatright JH; Grossniklaus HE; Nickerson JM
  • Complementation test of Rpe65 knockout and tvrm148.
    Invest Ophthalmol Vis Sci Volume: 54 Page(s): 5111 - 5122
    07/30/2013 Authors: Wright CB; Chrenek MA; Foster SL; Duncan T; Redmond TM; Pardue MT; Boatright JH; Nickerson JM
  • Extremely brief light-preconditioning in pigmented mouse model of light-induced retinal degeneration (LIRD)
    Volume: 54
    06/01/2013 Authors: Cunha P; Chrenek M; Sellers J; Boatright J
  • A Non-Radioactive Assay for Measuring Retinal Base Excision Repair Capability
    Volume: 54
    06/01/2013 Authors: Ciavatta V; Cunha P; Boatright J; Tang S
  • Hops Extract Xanthohumol Protects Visual Acuity and Function After Light Damage
    Volume: 54
    06/01/2013 Authors: Foster S; Henneman N; Chrenek M; Wright C; Boatright J
  • Comparison of retinal and cerebral inflammatory responses after middle cerebral artery occlusion
    Volume: 54
    06/01/2013 Authors: Allen R; Sayeed I; Cale H; Morrison K; Choi P; Boatright J; Pardue M; Stein D
  • Early Visual Stimulation Leads to Visual Enhancement
    Volume: 54
    06/01/2013 Authors: Mui A; Obertone T; Han M; Sellers J; Aung M; Park HN; Boatright J; Pardue M
  • Aerobic Exercise Preserves Retinal Function and Structure in Light Induced Retinal Degeneration Model
    Volume: 54
    06/01/2013 Authors: Lawson E; Han M; Sellers J; Chrenek M; Jafer S; Boatright J; Pardue M
  • Light induced retinal damage in 129sv pigmented mice
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 54
    06/01/2013 Authors: Chrenek M; Sellers J; Foster S; Zuelke D; Liao T; Nickerson J; Boatright J
  • The rd12 allele of Rpe65 exerts a dominant-negative effect on vision because it may exhibit altered intracytoplasmic trafficking
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 54
    06/01/2013 Authors: Wright C; Chrenek M; Foster S; Pardue M; Boatright J; Nickerson J
  • Molecular biomarkers in glaucoma.
    Invest Ophthalmol Vis Sci Volume: 54 Page(s): 121 - 131
    01/07/2013 Authors: Bhattacharya SK; Lee RK; Grus FH; Seventh ARVO/Pfizer Ophthalmics Research Institute Conference Working Group
  • Is the melatonin receptor type 1 involved in the pathogenesis of glaucoma?
    J Glaucoma Volume: 22 Suppl 5 Page(s): S49 - S50
    01/01/2013 Authors: Tosini G; Iuvone M; Boatright JH
  • On authentication of cell lines.
    Mol Vis Volume: 19 Page(s): 1848 - 1851
    01/01/2013 Authors: The Editors of Molecular Vision
  • Subretinal delivery and electroporation in pigmented and nonpigmented adult mouse eyes.
    Methods Mol Biol Volume: 884 Page(s): 53 - 69
    01/01/2012 Authors: Nickerson JM; Goodman P; Chrenek MA; Bernal CJ; Berglin L; Redmond TM; Boatright JH
  • Analysis of the RPE sheet in the rd10 retinal degeneration model.
    Adv Exp Med Biol Volume: 723 Page(s): 641 - 647
    01/01/2012 Authors: Chrenek MA; Dalal N; Gardner C; Grossniklaus H; Jiang Y; Boatright JH; Nickerson JM
  • DOPAMINE D4 RECEPTORS, RETINAL FUNCTION, AND SYNCHRONIZATION OF CIRCADIAN RHYTHMS IN THE MOUSE RETINA
    Volume: 118 Page(s): 36 - 36
    08/01/2011 Authors: Iuvone PM; Jackson CR; Chaurasia SS; Aseem F; Abey J; Hwang C; Pozdeyev N; Ziesel A; Wong P; Boatright JH
  • Exaggerated eye growth in IRBP-deficient mice in early development.
    Invest Ophthalmol Vis Sci Volume: 52 Page(s): 5804 - 5811
    07/29/2011 Authors: Wisard J; Faulkner A; Chrenek MA; Waxweiler T; Waxweiler W; Donmoyer C; Liou GI; Craft CM; Schmid GF; Boatright JH
  • Development of Bile Acids as Anti-Apoptotic and Neuroprotective Agents in Treatment of Ocular Disease
    Volume: 2 Page(s): 565 - 576
    01/01/2011 Authors: Foster SL; Kendall C; Lindsay AK; Ziesel AC; Allen RS; Mosley SS; Kim ES; Molinaro RJ; Edelhauser HF; Pardue MT
  • Drug and Gene Therapy Mediated by Physical Methods
    Volume: 2 Page(s): 391 - 408
    01/01/2011 Authors: Nickerson JM; Boatright JH
  • Retinal function and structure in Ant1-deficient mice.
    Invest Ophthalmol Vis Sci Volume: 51 Page(s): 6744 - 6752
    12/01/2010 Authors: Phillips MJ; Webb-Wood S; Faulkner AE; Jabbar SB; Biousse V; Newman NJ; Do VT; Boatright JH; Wallace DC; Pardue MT
  • Abnormal Globe Shape and Severe Myopia in the IRBP Knockout Mouse
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 51
    04/01/2010 Authors: Nickerson JM; Wisard JD; Chrenek MA; Wright CB; Boatright JH; Jabbar SB; Faulkner AE; Schmid GF; Pardue MT
  • Non-contact measurement of linear external dimensions of the mouse eye.
    J Neurosci Methods Volume: 187 Page(s): 156 - 166
    03/30/2010 Authors: Wisard J; Chrenek MA; Wright C; Dalal N; Pardue MT; Boatright JH; Nickerson JM
  • Bile acids in treatment of ocular disease.
    J Ocul Biol Dis Infor Volume: 2 Page(s): 149 - 159
    09/01/2009 Authors: Boatright JH; Nickerson JM; Moring AG; Pardue MT
  • The role of glia, mitochondria, and the immune system in glaucoma.
    Invest Ophthalmol Vis Sci Volume: 50 Page(s): 1001 - 1012
    03/01/2009 Authors: Tezel G; Fourth ARVO/Pfizer Ophthalmics Research Institute Conference Working Group
  • Drug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.
    Invest Ophthalmol Vis Sci Volume: 49 Page(s): 4712 - 4720
    11/01/2008 Authors: Edelhauser HF; Boatright JH; Nickerson JM; Third ARVO/Pfizer Research Institute Working Group
  • AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation.
    Invest Ophthalmol Vis Sci Volume: 49 Page(s): 4278 - 4283
    10/01/2008 Authors: Pang J-J; Boye SL; Kumar A; Dinculescu A; Deng W; Li J; Li Q; Rani A; Foster TC; Chang B
  • Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30.
    Invest Ophthalmol Vis Sci Volume: 49 Page(s): 2148 - 2155
    05/01/2008 Authors: Phillips MJ; Walker TA; Choi H-Y; Faulkner AE; Kim MK; Sidney SS; Boyd AP; Nickerson JM; Boatright JH; Pardue MT
  • Technical brief: subretinal injection and electroporation into adult mouse eyes.
    Mol Vis Volume: 14 Page(s): 2211 - 2226
    01/01/2008 Authors: Johnson CJ; Berglin L; Chrenek MA; Redmond TM; Boatright JH; Nickerson JM
  • Single-stranded oligonucleotide-mediated in vivo gene repair in the rd1 retina.
    Mol Vis Volume: 13 Page(s): 692 - 706
    05/02/2007 Authors: Andrieu-Soler C; Halhal M; Boatright JH; Padove SA; Nickerson JM; Stodulkova E; Stewart RE; Ciavatta VT; Doat M; Jeanny J-C
  • Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene.
    Vision Res Volume: 47 Page(s): 624 - 633
    03/01/2007 Authors: Chang B; Hawes NL; Pardue MT; German AM; Hurd RE; Davisson MT; Nusinowitz S; Rengarajan K; Boyd AP; Sidney SS
  • Tool from ancient pharmacopoeia prevents vision loss.
    Mol Vis Volume: 12 Page(s): 1706 - 1714
    12/29/2006 Authors: Boatright JH; Moring AG; McElroy C; Phillips MJ; Do VT; Chang B; Hawes NL; Boyd AP; Sidney SS; Stewart RE
  • Mouse retina has oligonucleotide-induced gene repair activity.
    Invest Ophthalmol Vis Sci Volume: 46 Page(s): 2291 - 2299
    07/01/2005 Authors: Ciavatta VT; Padove SA; Boatright JH; Nickerson JM
  • Retinoid processing proteins in the ocular ciliary epithelium.
    Mol Vis Volume: 11 Page(s): 356 - 365
    05/18/2005 Authors: Salvador-Silva M; Ghosh S; Bertazolli-Filho R; Boatright JH; Nickerson JM; Garwin GG; Saari JC; Coca-Prados M
  • Effect of chimeraplast structure and damaged target DNA on frequency of in vitro gene repair
    Volume: 46
    01/01/2005 Authors: Ciavatta VT; Trieu E; Boatright JH; Nickerson JM
  • Tauroursodeoxycholic acid (TUDCA) preserves photoreceptor function and morphology in rd10 mice at post-natal day 30
    Volume: 46
    01/01/2005 Authors: Phillips J; Boatright JH; Nickerson JM; Do VT; Pardue MT
  • Effect of tauroursodeoxycholic acid on mouse retinal ganglion cell degeneration following optic nerve transection
    Volume: 46
    01/01/2005 Authors: Boatright JH; Boyd AP; Garcia-Valenzuela E
  • Alternative RDO designs in gene repair assays with retinal nuclear extracts
    Volume: 45 Page(s): U150 - U150
    04/01/2004 Authors: Ciavatta VT; Padove SA; Boatright JH; Nickerson JM
  • Effect of tauroursodeoxycholic acid on retinal degeneration in rd10 mice
    Volume: 45 Page(s): U325 - U325
    04/01/2004 Authors: Boatright JH; Moring AG; McElroy CE; Do VT; Phillips MJ; Nickerson JM; Pardue MT
  • Initial growth factor expression profile in the RCS rat retina
    Volume: 45 Page(s): U323 - U323
    04/01/2004 Authors: Shuler RK; Phillips MJ; Fernandes A; Boatright JH; Chow AY; Nickerson JM; Pardue MT
  • Expression and regulation of components of the visual cycle CRALBP and IRBP in ciliary epithelial cells
    Volume: 45 Page(s): U476 - U476
    04/01/2004 Authors: Salvardor-Silva M; Bertazolli R; Ghosh S; Boatright JH; Nickerson JM; Crabb JW; Coca-Prados M
  • Delivery of dyes into intact mouse eyes by electrical fields
    Volume: 45 Page(s): U516 - U516
    04/01/2004 Authors: Nickerson JM; Wolchok SM; Ciavalta VT; Boatright JH
  • Delivery of several forms of DNA, DNA-RNA hybrids, and dyes across human sclera by electrical fields.
    Mol Vis Volume: 9 Page(s): 569 - 578
    10/15/2003 Authors: Davies JB; Ciavatta VT; Boatright JH; Nickerson JM
  • Targeting degradation of RNA by RNase H using DNA hairpins.
    Biochemistry Volume: 42 Page(s): 10945 - 10954
    09/23/2003 Authors: Li J; Bourdelat-Parks B; Boatright JH; Wartell RM
  • Targeting degradation of RNA by RNase H using DNA hairpins
    BIOCHEMISTRY Volume: 42 Page(s): 10945 - 10954
    09/23/2003 Authors: Li J; Bourdelat-Parks B; Boatright JH; Wartell RM
  • Genoplasty in mouse retina cells
    Volume: 44 Page(s): U404 - U404
    05/01/2003 Authors: Ciavatta VT; Padove SA; Boatright JH; Nickerson JM
  • Trans-scleral delivery of DNA and dyes by electrical fields
    Volume: 44 Page(s): U403 - U403
    05/01/2003 Authors: Nickerson JM; Davies JB; Boatright JH; Ciavatta VT
  • Partial purification and characterization of a mammalian IRBP tissue restricting factor
    Volume: 44 Page(s): U273 - U273
    05/01/2003 Authors: Rengarajan K; Stodulkova E; Boatright JH; Nickerson JM
  • Developmental analysis of the rd10 mouse
    Volume: 44 Page(s): U545 - U545
    05/01/2003 Authors: Boatright JH; Rengarajan K; Pardue MT; Moring AJG; Nickerson JM; Hawes NL; Chang B
  • Prevention of apoptosis in an RPE carcinoma cell line by bile acids
    Volume: 44 Page(s): U548 - U548
    05/01/2003 Authors: Do VT; Nickerson JM; Boatright JH
  • Oligonucleotide-mediated repair capability of human retina
    Volume: 44 Page(s): U404 - U404
    05/01/2003 Authors: Padove SA; Rengarajan K; Ciavatta VT; Nickerson JM; Boatright JH
  • Protective effects of tauroursodeoxycholic acid against oxidative damage in human retinoblastoma cells
    Volume: 44 Page(s): U549 - U549
    05/01/2003 Authors: Moring AJG; Nickerson JM; Boatright JH
  • Murine retinal/RPE/choroidal expression of ABCA1, ACAT1 and ACAT2
    Volume: 43 Page(s): U609 - U609
    05/01/2002 Authors: Lee SJ; Shuler RK; Sippy BD; Nickerson J; Boatright J; Grossniklaus HE
  • Initial investigation of gene repair in ocular tissues
    Volume: 43 Page(s): U1305 - U1305
    05/01/2002 Authors: Shuler RK; Boatright JH; Stodulkova E; Rengarajan K; Padove SA; Nickerson JM
  • Identification of a mammalian IRBP tissue restricting transcription factor by EMSA and UV photo-crosslinking and SDS-PAGE
    Volume: 43 Page(s): U1011 - U1011
    05/01/2002 Authors: Rengarajan K; Stodulkova E; Do VT; Boatright JH; Nickerson JM
  • The effect of retinoids and butyrate on the expression of CRX and IRBP in retinoblastoma cells
    Volume: 43 Page(s): U1013 - U1013
    05/01/2002 Authors: Boatright JH; Stodulkova E; Nguyen HT; Do VT; Nickerson JM
  • Characterization of DNA/protein complexes that restrict IRBP expression
    Volume: 43 Page(s): U1014 - U1014
    05/01/2002 Authors: Padove SA; Do VT; Nguyen HT; Nickerson JM; Boatright JH
  • ABCA1 expression in human RPE cells and age-related macular degeneration
    Volume: 43 Page(s): U610 - U610
    05/01/2002 Authors: Sippy BD; Shuler RK; Lee SJ; Couse T; Wilcox JN; Boatright JH; Nickerson JM; Grossniklaus HE
  • The effect of retinoids and butyrate on the expression of CRX and IRBP in retinoblastoma cells.
    Vision Res Volume: 42 Page(s): 933 - 938
    04/01/2002 Authors: Boatright JH; Stodulkova E; Do VT; Padove SA; Nguyen HT; Borst DE; Nickerson JM
  • Endogenous CRX expression and IRBP promoter activity in retinoblastoma cells.
    Brain Res Volume: 916 Page(s): 136 - 142
    10/19/2001 Authors: Boatright JH; Borst DE; Stodulkova E; Nickerson JM
  • Evidence of a tissue-restricting DNA regulatory element in the mouse IRBP promoter.
    FEBS Lett Volume: 504 Page(s): 27 - 30
    08/24/2001 Authors: Boatright JH; Knox BE; Jones KM; Stodulkova E; Nguyen HT; Padove SA; Borst DE; Nickerson JM
  • Structural characterization and comparison of promoter activity of mouse and bovine interphotoreceptor retinoid-binding protein (IRBP) gene 5' flanking regions in WERI, Y79, chick retina cells, and transgenic mice.
    Curr Eye Res Volume: 23 Page(s): 20 - 32
    07/01/2001 Authors: Borst DE; Boatright JH; Si JS; Stodulkova E; Remaley N; Pallansch LA; Nickerson JM
  • Initial test of chimeraplasty in correcting a mouse retinal degeneration.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 42 Page(s): S346 - S346
    03/15/2001 Authors: Stodulkova E; Rengarajan K; Takasu I; Martin WD; Padove SA; Saperstein DA; Nickerson JM; Boatright JH
  • Extra-hepatic expression of serum albumin mRNA in mouse retina.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 42 Page(s): S773 - S773
    03/15/2001 Authors: Nickerson JM; Dodson CS; Rengarajan K; Gewant HD; Stodulkova E; Nguyen HT; Boatright JH
  • Tissue-restricting DNA regulatory elements in the mouse IRBP promoter.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 42 Page(s): S353 - S353
    03/15/2001 Authors: Boatright JH; Knox BE; Stodulkova E; Nguyen HT; Padove SA; Matheu EA; Borst DE; Nickerson JM
  • Initial isolation of IRBP tissue restricting trans-acting factors.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 42 Page(s): S353 - S353
    03/15/2001 Authors: Padove SA; Nguyen HT; Nickerson JM; Zhang K; Baehr W; Boatright JH
  • Extra-hepatic expression of serum albumin mRNA in mouse retina.
    Curr Eye Res Volume: 22 Page(s): 182 - 189
    03/01/2001 Authors: Dodson CS; Rengarajan K; Gewant HD; Stodulkova E; Nguyen HT; Boatright JH; Nickerson JM
  • Site-specific DNA hypomethylation permits expression of the IRBP gene.
    Brain Res Volume: 887 Page(s): 211 - 221
    12/22/2000 Authors: Boatright JH; Nickerson JM; Borst DE
  • Effects of dispersed point substitutions in Repeat 1 of human interphotoreceptor retinoid binding protein (IRBP).
    Mol Vis Volume: 6 Page(s): 40 - 50
    04/07/2000 Authors: Gross EA; Li GR; Ruuska SE; Boatright JH; Mian IS; Nickerson JM
  • G239T mutation in Repeat 1 of human IRBP: possible implications for more than one binding site in a single repeat.
    Mol Vis Volume: 6 Page(s): 51 - 62
    04/07/2000 Authors: Gross EA; Li GR; Ruuska SE; Boatright JH; Nickerson JM
  • Prediction of structural and functional relationships of Repeat 1 of human interphotoreceptor retinoid-binding protein (IRBP) with other proteins.
    Mol Vis Volume: 6 Page(s): 30 - 39
    04/07/2000 Authors: Gross EA; Li GR; Lin ZY; Ruuska SE; Boatright JH; Mian IS; Nickerson JM
  • Endogenous Crx expression and IRBP promoter activity in retinoblastoma cells.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 41 Page(s): S388 - S388
    03/15/2000 Authors: Boatright JH; Wang QL; Chen S; Zack DJ; Borst DE; Nickerson JM
  • Biochemical and biophysical properties of repeats of human IRBP.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 41 Page(s): S331 - S331
    03/15/2000 Authors: Nickerson JM; Li GR; Boatright JH; Rengarajan K; Ruuska SE
  • Characterization of the beta 3 integrin subunit gene promoter in transiently transfected expressing and non-expressing cells.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 41 Page(s): S636 - S636
    03/15/2000 Authors: Chen T; Saperstein DA; Boatright JH; Bray P; Herman IM
  • IRBP promoter activity requires endogenous CRX
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 40 Page(s): S939 - S939
    03/15/1999 Authors: Boatright JH; Peoples JW; Wang QS; Chen S; Zack DJ; Nickerson JH
  • A major cis activator of the IRBP gene contains CRX-binding and Ret-1/PCE-I elements.
    Mol Vis Volume: 3 Page(s): 15
    12/22/1997 Authors: Boatright JH; Borst DE; Peoples JW; Bruno J; Edwards CL; Si JS; Nickerson JM
  • The 5' flanking regions of IRBP and arrestin have promoter activity in primary embryonic chicken retina cell cultures.
    Exp Eye Res Volume: 64 Page(s): 269 - 277
    02/01/1997 Authors: Boatright JH; Buono R; Bruno J; Lang RK; Si JS; Shinohara T; Peoples JW; Nickerson JM
  • Electronic publishing.
    Science Volume: 270 Page(s): 217 - 218
    10/13/1995 Authors: Boatright JH; Nickerson JM; Church RL
  • FUNCTIONAL-CHARACTERIZATION OF CIS-ACTING REGULATORY ELEMENTS OF THE IRBP GENE PROMOTER REGION
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 36 Page(s): S123 - S123
    03/15/1995 Authors: BOATRIGHT JH; BORST DE; LIN ZY; SI JS; BHATI M; PATEL D; BRUNO J; NICKERSON JM
  • Ligand-binding properties of recombinant human IRBP
    Page(s): 395 - 402
    01/01/1995 Authors: Nickerson JM; Mody V; DeGuzman C; Heron KA; Marciante K; Boatright J; Si JS; Lin ZY
  • Inhibition of endogenous dopamine release in amphibian retina by L-2-amino-4-phosphonobutyric acid (L-AP4) and trans-2-aminocyclopentane-1,3-dicarboxylate (ACPD).
    Brain Res Volume: 649 Page(s): 339 - 342
    06/27/1994 Authors: Boatright JH; Gordon JR; Iuvone PM
  • CHARACTERIZATION OF TRANS-ACTING FACTORS AND CIS-ACTING ELEMENTS IN THE IRBP GENE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 35 Page(s): 1578 - 1578
    03/15/1994 Authors: BOATRIGHT JH; BORST DE; NAGPAL S; RAM H; NICKERSON JM
  • Regulation of endogenous dopamine release in amphibian retina by melatonin: the role of GABA.
    Vis Neurosci Volume: 11 Page(s): 1013 - 1018
    01/01/1994 Authors: Boatright JH; Rubim NM; Iuvone PM
  • Regulation of endogenous dopamine release in amphibian retina by gamma-aminobutyric acid and glycine.
    Vis Neurosci Volume: 11 Page(s): 1003 - 1012
    01/01/1994 Authors: Boatright JH; Rubim NM; Iuvone PM
  • NMDA RECEPTORS REGULATE DOPAMINE RELEASE IN AMPHIBIAN RETINA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 34 Page(s): 1063 - 1063
    03/15/1993 Authors: RUBIM NM; BOATRIGHT JH; GORDON JR; IUVONE PM
  • PROTEIN AND DNA COMPLEXES IN THE DISTAL 5' FLANKING REGION OF THE IRBP GENE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 34 Page(s): 830 - 830
    03/15/1993 Authors: BOATRIGHT J; RAM H; NICKERSON J
  • 2-AMINO-4-PHOSPHONOBUTYRIC ACID (AP-4) BLOCKS LIGHT-EVOKED DOPAMINE RELEASE IN FROG RETINA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 33 Page(s): 1405 - 1405
    03/15/1992 Authors: BOATRIGHT JH; GORDON JR; IUVONE PM
  • MDL 12,330A, AN INHIBITOR OF ADENYLATE-CYCLASE ACTIVITY, INHIBITS INDUCTION OF SEROTONIN N-ACETYLTRANSFERASE ACTIVITY IN RETINA AND PINEAL-GLAND
    FASEB JOURNAL Volume: 5 Page(s): A1499 - A1499
    03/19/1991 Authors: BOATRIGHT JH; GAN J; BUTLER BJ; AVENDANO G; IUVONE PM
  • MULTIPLE INHIBITORY MODULATORS OF DOPAMINE RELEASE IN FROG RETINA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 32 Page(s): 1261 - 1261
    03/15/1991 Authors: BOATRIGHT JH; IUVONE PM
  • Stimulation of endogenous dopamine release and metabolism in amphibian retina by light- and K+-evoked depolarization.
    Brain Res Volume: 482 Page(s): 164 - 168
    03/13/1989 Authors: Boatright JH; Hoel MJ; Iuvone PM
  • GABA and the regulation of serotonin N-acetyltransferase activity in amphibian retina-II. The role of dopamine.
    Neurochem Int Volume: 15 Page(s): 549 - 554
    01/01/1989 Authors: Boatright JH; Iuvone PM
  • GABA and the regulation of serotonin N-acetyltransferase activity in amphibian retina-I. Effects of GABA agonists and antagonists.
    Neurochem Int Volume: 15 Page(s): 541 - 547
    01/01/1989 Authors: Boatright JH; Iuvone PM
  • Dopamine mediates the light-evoked suppression of serotonin N-acetyltransferase activity in retina.
    Brain Res Volume: 418 Page(s): 314 - 324
    08/25/1987 Authors: Iuvone PM; Boatright JH; Bloom MM
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements